Nicotine pouches can be dangerous to children if they use, touch, chew on, or eat them. These small fiber pouches, which contain nicotine that is chemically synthesized or derived from the tobacco leaf, can cause nicotine poisoning in children. It’s important to keep these products away from kids and to be prepared in case of accidental exposure or ingestion. During...
Endometrial cancer (cancer of the lining of the uterus) is one of the most common cancers in women worldwide. Cases are rising, partly due to aging populations, obesity, and diabetes. But new advances in prevention, diagnosis, and treatment are offering hope. What is Endometrial Cancer and Why Is It Rising? Endometrial cancer happens when cells in the lining of the...
For Immediate Release: September 03, 2025 The U.S. Food and Drug Administration today introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect....
For Immediate Release: September 10, 2025 Despite recent declines, opioids remain commonly prescribed to about 1 in 5 U.S. adults who live with chronic pain as effective alternatives are limited. As part of its broader strategy to address the opioid crisis, the U.S. Food and Drug Administration today issued draft guidance titled “Development of Non-Opioid Analgesics...
What Did the Research Discover? This study explored whether stopping metformin therapy—particularly for reasons unrelated to kidney dysfunction—was linked to an increased risk of developing dementia. Researchers analyzed data from Kaiser Permanente Northern California, following over 41,000 metformin users for up to 24 years. The findings revealed that individuals...
A new 2024 study in Frontiers in Oncology looked at sacituzumab govitecan, a targeted therapy for triple-negative breast cancer (TNBC)—a fast-growing cancer with fewer treatment options. Already FDA-approved, this drug continues to show promising results, even in real-world settings, for women who’ve run out of standard treatment options.